Most Popular
![[KH Explains] How should Korea adjust its trade defenses against Chinese EVs?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/15/20240415050562_0.jpg&u=20240415144419)
SK Holdings Co., the holding firm for Korea’s third-largest conglomerate, SK Group, said Friday it plans to spin off its life science business unit in April in a bid to nurture new growth engines.
The new entity, tentatively named SK Biopharm, will be launched on April 1 with a paid-in capital of 20 billion won ($18 million), SK said in a regulatory filing.
Since launching a drug development business in 1993, SK has conducted various research projects and production on drugs for the central nervous system.
The spin-off plan is set to be finalized in a shareholders’ meeting next month, according to SK. (Yonhap News)
The new entity, tentatively named SK Biopharm, will be launched on April 1 with a paid-in capital of 20 billion won ($18 million), SK said in a regulatory filing.
Since launching a drug development business in 1993, SK has conducted various research projects and production on drugs for the central nervous system.
The spin-off plan is set to be finalized in a shareholders’ meeting next month, according to SK. (Yonhap News)
![[Today’s K-pop] Stray Kids to return soon: report](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/04/16/20240416050713_0.jpg&u=)